Functional assays demonstrated that silencing TMEM86B effectively inhibited CRC cell viability, as evidenced by reduced cell proliferation and clonogenicity in both the cell proliferation assays and colony formation assays (Figures 11C,E). Here, TMEM86B is linked to colorectal carcinoma.